Oarsman Capital’s Cardinal Health CAH Stock Holding History

Oarsman Capital’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-445	Closed	-$52.6K	–	338
2024 Q4	$52.6K	Hold	445	–	–	0.01%	432
2024 Q3	$49.2K	Buy	+445	New	+$46.5K	0.01%	455

Other funds holding CAH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Oarsman Capital's CAH Position: Q1 2025 in Review

Oarsman Capital sold out of Cardinal Health (CAH) in Q1 2025, closing a stake of 445 shares — an estimated $52.6K sold.

Oarsman Capital first reported a position in CAH in Q3 2024 and held it in 2 quarters. The position peaked at $52.6K in Q4 2024. 1,148 funds tracked by Wall St. Rank hold CAH as of Q1 2025.

Oarsman Capital reported no remaining Cardinal Health position as of Q1 2025 after selling out during the quarter.
Oarsman Capital sold 445 Cardinal Health shares in Q1 2025, an estimated $52.6K.
Oarsman Capital first reported a position in Cardinal Health in Q3 2024 and held it in 2 quarters.
Oarsman Capital's Cardinal Health position peaked at $52.6K in Q4 2024.
1,148 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2025.

Based on Oarsman Capital's 13F filing for Q1 2025, filed 14 May 2025.